Saudi Food and Drug Authority Suspends The Authorisation of Rosiglitazone
The Saudi food and Drug Authority has reviewed the safety of Rosiglitazone (Avandia®) which used in treatment of type 2 diabetes mellitus and marketed in Saudi Arabia as Avandia®. Based on growing evidence from clinical trials meta-analyses and observational studies indicating serious cardiovascular adverse ..more

In Collaboration with SFDA: King Faisal Specialist Hospital & Research Center Inaugurates the International Radiology Conference
In the presence of H.E Chief Executive Officer of the Saudi Food & Drug Authority and H.E Dr. Qassim Al Qassabi, General Executive Supervisor of KFSH&RC, the International Radiology Conference and Exhibition was inaugurated ..more

Saudi FDA alerts Hospitals & Health Care Providers about using Blood Sugar Test Tapes type ' One Touch Sure Step'
In accordance with Saudi food and drug authority efforts, represented by the National Center for medical devices reporting through its surveillance for the quality and safety of medical devices marketed in Saudi Arabia. Saudi FDA alerts ..more

Saudi FDA organizes a workshop on "SPS and their Mechanism" at WTO

Saudi FDA Cancels the Registration of Aupent Product